Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(7%)
Results Posted
11%(1 trials)

Phase Distribution

Ph not_applicable
5
36%
Ph early_phase_1
1
7%
Ph phase_1
2
14%
Ph phase_3
1
7%
Ph phase_4
5
36%

Phase Distribution

3

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
1(7.1%)
Phase 1Safety & dosage
2(14.3%)
Phase 3Large-scale testing
1(7.1%)
Phase 4Post-market surveillance
5(35.7%)
N/ANon-phased studies
5(35.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(9)
Other(3)

Detailed Status

Completed9
unknown3
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.1%)
Phase 12 (14.3%)
Phase 31 (7.1%)
Phase 45 (35.7%)
N/A5 (35.7%)

Trials by Status

completed964%
not_yet_recruiting17%
unknown321%
active_not_recruiting17%

Recent Activity

1 active trials
Showing 5 of 14
not_yet_recruitingnot_applicable

Clinical and Radiographic Assessment of Neo Putty MTA Versus Formocresol Used in Vital Pulpotomy of Mandibular Primary Molars

NCT07437794
active_not_recruitingnot_applicable

New Vital Pulpotomy Medications in Primary Molars

NCT05937100
completedphase_4

Lasers as an Alternative to Formocresol and Sodium Hypochlorite Medicaments in Pulpotomy Techniques

NCT06002646
completednot_applicable

Clinical, Radiographic and Patient Acceptance Evaluation of LASER Compared to Formocresol Pulpotomies inPrimary Molars

NCT06200818
completedphase_1

Allium Sativum Oil as Alternative Non-vital Pulpotomy Medicament in Primary Teeth

NCT05801367
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT07437794Not Applicable

Clinical and Radiographic Assessment of Neo Putty MTA Versus Formocresol Used in Vital Pulpotomy of Mandibular Primary Molars

Not Yet Recruiting
NCT05937100Not Applicable

New Vital Pulpotomy Medications in Primary Molars

Active Not Recruiting
NCT06002646Phase 4

Lasers as an Alternative to Formocresol and Sodium Hypochlorite Medicaments in Pulpotomy Techniques

Completed
NCT06200818Not Applicable

Clinical, Radiographic and Patient Acceptance Evaluation of LASER Compared to Formocresol Pulpotomies inPrimary Molars

Completed
NCT05801367Phase 1

Allium Sativum Oil as Alternative Non-vital Pulpotomy Medicament in Primary Teeth

Completed
NCT05801354Phase 1

Turmeric Gel as Alternative Non-vital Pulpotomy Medicament in Primary Teeth

Completed
NCT05723900Not Applicable

Evaluation of Pulp Response to Castor Oil

Completed
NCT05314842Phase 3

Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol

Unknown
NCT05190783Phase 4

Partial Versus Complete Pulpotomy Using Three Different Materials in Primary Molars: a Clinical Study

Completed
NCT04397094Phase 4

Theracal Pulpotomy in Primary Molars

Completed
NCT03779698Phase 4

BiodentineTM Versus Formocresol Pulpotomy Technique in Primary Molars

Completed
NCT03582319Not Applicable

Clinical and Radiographic Evaluation of Biodentine Versus Formocresol

Completed
NCT03254290Early Phase 1

Color Stability of NeoMTA Pulpotomized Primary Teeth

Unknown
NCT02286648Phase 4

Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars

Unknown

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14